Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors
- PMID: 33664967
- PMCID: PMC7906269
- DOI: 10.1093/nop/npaa061
Systematic review of the incidence and risk factors for cerebral vasculopathy and stroke after cranial proton and photon radiation for childhood brain tumors
Abstract
Background: The aim of our study is to determine the incidence, timing, and risk factors for cerebral vasculopathy after cranial proton and photon radiation for pediatric brain tumors.
Methods: We performed a single-institution retrospective review of a cohort of children treated with proton radiation for brain tumors. MRA and/or MRI were reviewed for evidence of cerebral vascular stenosis and infarcts. Twenty-one similar studies (17 photon, 4 proton) were identified by systematic literature review.
Results: For 81 patients with median follow-up of 3 years, the rates of overall and severe vasculopathy were 9.9% and 6.2% respectively, occurring a median of 2 years post radiation. Dose to optic chiasm greater than 45 Gy and suprasellar location were significant risk factors. Results were consistent with 4 prior proton studies (752 patients) that reported incidence of 5% to 6.7%, 1.5 to 3 years post radiation. With significantly longer follow-up (3.7-19 years), 9 studies (1108 patients) with traditional photon radiation reported a higher rate (6.3%-20%) and longer time to vasculopathy (2-28 years). Significant risk factors were neurofibromatosis type 1 (NF-1; rate 7.6%-60%) and suprasellar tumors (9%-20%). In 10 studies with photon radiation (1708 patients), the stroke rate was 2% to 18.8% (2.3-24 years post radiation).
Conclusions: Childhood brain tumor survivors need screening for vasculopathy after cranial radiation, especially with higher dose to optic chiasm, NF-1, and suprasellar tumors. Prospective studies are needed to identify risk groups, and ideal modality and timing, for screening of this toxicity.
Keywords: cerebral vasculopathy; childhood brain tumors; photon radiation; proton radiation; stroke.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Figures


Similar articles
-
Risk of Radiation Vasculopathy and Stroke in Pediatric Patients Treated With Proton Therapy for Brain and Skull Base Tumors.Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):854-859. doi: 10.1016/j.ijrobp.2018.03.027. Epub 2018 Mar 29. Int J Radiat Oncol Biol Phys. 2018. PMID: 29730064
-
Radiation-Induced Large Vessel Cerebral Vasculopathy in Pediatric Patients With Brain Tumors Treated With Proton Radiation Therapy.Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):817-824. doi: 10.1016/j.ijrobp.2017.07.009. Epub 2017 Jul 12. Int J Radiat Oncol Biol Phys. 2017. PMID: 28867358
-
Evaluation and treatment of children with radiation-induced cerebral vasculopathy.J Neurosurg Pediatr. 2019 Sep 20;24(6):680-688. doi: 10.3171/2019.7.PEDS19188. Print 2019 Dec 1. J Neurosurg Pediatr. 2019. PMID: 31629322
-
Risk of secondary malignant neoplasms in children following proton therapy vs. photon therapy for primary CNS tumors: A systematic review and meta-analysis.Front Oncol. 2022 Aug 12;12:893855. doi: 10.3389/fonc.2022.893855. eCollection 2022. Front Oncol. 2022. PMID: 36033525 Free PMC article.
-
Proton therapy for pediatric diencephalic tumors.Front Oncol. 2023 May 5;13:1123082. doi: 10.3389/fonc.2023.1123082. eCollection 2023. Front Oncol. 2023. PMID: 37213290 Free PMC article. Review.
Cited by
-
Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007.Front Oncol. 2023 Oct 27;13:1180993. doi: 10.3389/fonc.2023.1180993. eCollection 2023. Front Oncol. 2023. PMID: 37965466 Free PMC article.
-
Stroke in Asia.Cerebrovasc Dis Extra. 2024;14(1):58-75. doi: 10.1159/000538928. Epub 2024 Apr 26. Cerebrovasc Dis Extra. 2024. PMID: 38657577 Free PMC article. Review.
-
Delayed radiation-induced cerebral vasculopathy mimicking tumour in an adolescent 14 years after radiation therapy for posterior fossa ependymoma.BMJ Case Rep. 2024 May 6;17(5):e260574. doi: 10.1136/bcr-2024-260574. BMJ Case Rep. 2024. PMID: 38719251 No abstract available.
-
Radiation therapy for childhood-onset craniopharyngioma: systematic review and meta-analysis.J Neurooncol. 2025 Mar;172(1):89-98. doi: 10.1007/s11060-024-04914-w. Epub 2025 Jan 3. J Neurooncol. 2025. PMID: 39751704
-
Proton Radiation Therapy: A Systematic Review of Treatment-Related Side Effects and Toxicities.Int J Mol Sci. 2024 Oct 11;25(20):10969. doi: 10.3390/ijms252010969. Int J Mol Sci. 2024. PMID: 39456752 Free PMC article.
References
-
- Gajjar A, Chintagumpala M, Ashley D, et al. . Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813–820. - PubMed
-
- Packer RJ, Gajjar A, Vezina G, et al. . Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24(25): 4202–4208. - PubMed
-
- Jensen AW, Laack NNI, Buckner JC, Schomberg PJ, Wetmore CJ, Brown PD.. Long-term follow-up of dose-adapted and reduced-field radiotherapy with or without chemotherapy for central nervous system germinoma. Int J Radiat Oncol Biol Phys. 2010;77(5):1449–1456. - PubMed
-
- Kiehna EN, Merchant TE. Radiation therapy for pediatric craniopharyngioma. Neurosurg Focus. 2010;28(4):E10. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous